Literature DB >> 19526774

[Survey of investigations on Daodi Chinese medicinal materials in China since 1980s].

Xiaohe Xiao1, Shilin Chen, Luqi Huang, Peigen Xiao.   

Abstract

In the recent 20 years, three major investigational achievements about Daodi CMM (Chinese medicinal materials) have been made as follows: (1) The herbal textual about Daodi CMM have been collected and revised systematically, and the causes and pattern of Daodi CMM formation and development were illustrated. (2) A series of appraising methods and marks for Daodi CMM have been set up initially, the scientific connotation of Daodi CMM has been clarified primarily, which promotes the development of pharmacognosy discipline consequently. (3) Based on the Daodi CMM research program, the GAP of CMM with good quality, high yield and best benefit has been carried out elementarily, which is helpful to solve some economic problems and troubles which the peasant, countryside and agriculture always worry about. However, there are still some puzzles and misunderstandings about Daodi CMM to be treated with seriously. The main research aspects of Daodi CMM in the future could be focused on: (1) Identification and authentication of the species and producing area of Daodi CMM. (2) Establishment and implement of the commercial specification criterion of Daodi CMM. (3) Standardization of the planting and processing technologies for Daodi CMM.

Mesh:

Substances:

Year:  2009        PMID: 19526774

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

1.  Distribution patterns and industry planning of commonly used traditional Chinese medicinal plants in China.

Authors:  Zhang-Jian Shan; Jian-Fei Ye; Da-Cheng Hao; Pei-Gen Xiao; Zhi-Duan Chen; An-Ming Lu
Journal:  Plant Divers       Date:  2021-11-19

2.  Quality Variation of Goji (Fruits of Lycium spp.) in China: A Comparative Morphological and Metabolomic Analysis.

Authors:  Ruyu Yao; Michael Heinrich; Yuanfeng Zou; Eike Reich; Xiaolei Zhang; Yu Chen; Caroline S Weckerle
Journal:  Front Pharmacol       Date:  2018-02-26       Impact factor: 5.810

Review 3.  Evidence-Based Study to Compare Daodi Traditional Chinese Medicinal Material and Non-Daodi Traditional Chinese Medicinal Material.

Authors:  Xingyue Yang; Xin Tian; Yannan Zhou; Yali Liu; Xinlong Li; Tingting Lu; Changhe Yu; Liyun He
Journal:  Evid Based Complement Alternat Med       Date:  2018-01-22       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.